Leiio Wellness Announces Oversubscribed $3.5 Million Private Placement to Accelerate Growth and Early Revenue Streams
California and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Leiio Wellness Ltd. ("Leiio" or the "Company"), a U.S. focused, premium brain performance brand centered around psychedelic mushrooms, is pleased to announce it has completed a second capital raise securing an additional $3.5 million to accelerate growth. The round was joined by existing and new investors, bringing total funds raised to approximately $5.5 million over the past five months. The closing today puts Leiio in the...
2021-07-14 5:05 PM EDT
Leiio Wellness Announces Formation of World-Class Advisory Board
Calgary, Alberta--(Newsfile Corp. - May 11, 2021) - Leiio Wellness Ltd. ("Leiio" or the "Company"), a premium brain performance brand fueled by mushrooms, is pleased to announce the formation of an impressive advisory board consisting of a group of highly respected medical, clinical, technological, regulatory and research experts. Mauro Zappaterra, MD, PhD brings both medical and clinical expertise to LEIIO. Mauro graduated from Harvard Medical School and specializes in Physical Medicine and...
2021-05-11 7:00 AM EDT
LEIIO Wellness and MAACKK Capital Corp. Announce Closing of C$2,000,000 Private Placement and Signing of Letter of Intent for Reverse Take-Over of MAACKK Capital
Calgary, Alberta--(Newsfile Corp. - March 4, 2021) - LEIIO Wellness Ltd. ("LEIIO" or the "Company"), a premium health and wellness company dedicated to optimizing mental performance through mushroom-derived nootropics and psilocybin microdoses, and MAACKK Capital Corp. ("MAACKK") are pleased to announce the closing of a C$2,000,000 private placement financing (the "Placement") and the signing of a letter of intent ("LOI") for a reverse take-over transaction (the "Transaction") of MAACKK by...
2021-03-04 4:48 PM EST